These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3135392)

  • 21. Double-blind trial of recombinant gamma-interferon versus placebo in the treatment of rheumatoid arthritis.
    Cannon GW; Pincus SH; Emkey RD; Denes A; Cohen SA; Wolfe F; Saway PA; Jaffer AM; Weaver AL; Cogen L
    Arthritis Rheum; 1989 Aug; 32(8):964-73. PubMed ID: 2504171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Divergent effect of cyclosporine on Th1/Th2 type cytokines in patients with severe, refractory rheumatoid arthritis.
    Kim WU; Cho ML; Kim SI; Yoo WH; Lee SS; Joo YS; Min JK; Hong YS; Lee SH; Park SH; Cho CS; Kim HY
    J Rheumatol; 2000 Feb; 27(2):324-31. PubMed ID: 10685792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Results of a multicenter placebo-controlled double-blind randomized phase III clinical study of treatment of rheumatoid arthritis with recombinant interferon-gamma.
    Lemmel EM; Brackertz D; Franke M; Gaus W; Hartl PW; Machalke K; Mielke H; Obert HJ; Peter HH; Sieper J
    Rheumatol Int; 1988; 8(2):87-93. PubMed ID: 3135572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
    Musch E; Högemann B; Gerritzen A; Fischer HP; Wiese M; Kruis W; Malek M; Gugler R; Schmidt G; Huchzermeyer H; Gerlach U; Dengler HJ; Sauerbruch T
    Hepatogastroenterology; 1998; 45(24):2282-94. PubMed ID: 9951911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and efficacy of T-614 in the treatment of patients with active rheumatoid arthritis: a double blind, randomized, placebo-controlled and multicenter trial.
    Lü LJ; Teng JL; Bao CD; Han XH; Sun LY; Xu JH; Li XF; Wu HX
    Chin Med J (Engl); 2008 Apr; 121(7):615-9. PubMed ID: 18466681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
    Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
    Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of tacrolimus in rheumatoid arthritis patients who have been treated unsuccessfully with methotrexate: a six-month, double-blind, randomized, dose-ranging study.
    Furst DE; Saag K; Fleischmann MR; Sherrer Y; Block JA; Schnitzer T; Rutstein J; Baldassare A; Kaine J; Calabrese L; Dietz F; Sack M; Senter RG; Wiesenhutter C; Schiff M; Stein CM; Satoi Y; Matsumoto A; Caldwell J; Harris RE; Moreland LW; Hurd E; Yocum D; Stamler DA
    Arthritis Rheum; 2002 Aug; 46(8):2020-8. PubMed ID: 12209503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concomitant medication use in a large, international, multicenter, placebo controlled trial of anakinra, a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis.
    Tesser J; Fleischmann R; Dore R; Bennett R; Solinger A; Joh T; Modafferi D; Schechtman J;
    J Rheumatol; 2004 Apr; 31(4):649-54. PubMed ID: 15088288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Neutralisation of interferon gamma--a new trend in therapy of rheumatoid arthritis].
    Nasonova VA; Lukina GV; Sigidin IaA
    Ter Arkh; 2008; 80(5):30-7. PubMed ID: 18590111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The clinical effect of glucocorticoids in patients with rheumatoid arthritis may be masked by decreased use of additional therapies.
    van Everdingen AA; Siewertsz van Reesema DR; Jacobs JW; Bijlsma JW
    Arthritis Rheum; 2004 Apr; 51(2):233-8. PubMed ID: 15077265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and efficacy of Ganoderma lucidum (lingzhi) and San Miao San supplementation in patients with rheumatoid arthritis: a double-blind, randomized, placebo-controlled pilot trial.
    Li EK; Tam LS; Wong CK; Li WC; Lam CW; Wachtel-Galor S; Benzie IF; Bao YX; Leung PC; Tomlinson B
    Arthritis Rheum; 2007 Oct; 57(7):1143-50. PubMed ID: 17907228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and tolerability of valdecoxib in treating the signs and symptoms of severe rheumatoid arthritis: a 12-week, multicenter, randomized, double-blind, placebo-controlled study.
    Gibofsky A; Rodrigues J; Fiechtner J; Berger M; Pan S
    Clin Ther; 2007 Jun; 29(6):1071-85. PubMed ID: 17692722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Gamma interferon in psoriatic arthritis].
    Fierlbeck G; Rassner G
    Dtsch Med Wochenschr; 1986 Aug; 111(35):1313-6. PubMed ID: 3091352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: a randomized, controlled trial.
    Lambert CM; Sandhu S; Lochhead A; Hurst NP; McRorie E; Dhillon V
    Arthritis Rheum; 2004 Feb; 50(2):364-71. PubMed ID: 14872477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interim results on the clinical effects of i.v. administered thymopentin in active rheumatoid arthritis.
    Malaise M; Franchimont P; Hauwaert C; Danneskiold-Samsoe B; Gross D; Gerber H; Gerschpacher H; Bolla K
    Int J Clin Pharmacol Res; 1984; 4(6):451-7. PubMed ID: 6398314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Double-blind trial of the effectiveness of antibodies to interferon-gamma and tumor necrosis factor-alpha in rheumatoid arthritis (preliminary results)].
    Lukina GV; Sigidin IaA; Skurkovich SV; Skurkovich BS
    Ter Arkh; 2001; 73(5):12-5. PubMed ID: 11517739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Double-blind crossover study to evaluate the efficacy of a single daily dose of naproxen in rheumatoid arthritis.
    Katona G; Vargas RB
    Eur J Rheumatol Inflamm; 1983; 6(3):233-41. PubMed ID: 6391928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of etanercept 50 mg twice a week in patients with rheumatoid arthritis who had a suboptimal response to etanercept 50 mg once a week: results of a multicenter, randomized, double-blind, active drug-controlled study.
    Weinblatt ME; Schiff MH; Ruderman EM; Bingham CO; Li J; Louie J; Furst DE
    Arthritis Rheum; 2008 Jul; 58(7):1921-30. PubMed ID: 18576334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravenous human recombinant tumor necrosis factor receptor p55-Fc IgG1 fusion protein, Ro 45-2081 (lenercept): results of a dose-finding study in rheumatoid arthritis.
    Furst DE; Weisman M; Paulus HE; Bulpitt K; Weinblatt M; Polisson R; Zaug M; Kneer J; Van der Auwera P; Stevens RM
    J Rheumatol; 2003 Oct; 30(10):2123-6. PubMed ID: 14528504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of willow bark extract in the treatment of osteoarthritis and rheumatoid arthritis: results of 2 randomized double-blind controlled trials.
    Biegert C; Wagner I; Lüdtke R; Kötter I; Lohmüller C; Günaydin I; Taxis K; Heide L
    J Rheumatol; 2004 Nov; 31(11):2121-30. PubMed ID: 15517622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.